Weinberg Uri
Chf Medical and Innovation Ofr at NVCR
- Sold, on record
- $5.6M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Mar 4, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NVCRNovoCure LtdChf Medical and Innovation Ofr
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NVCRPlan not statedMay 10, 2021 2021
Sold 5,650 shares at $189.65 ($1.1M)
Weinberg Uri, Chief Science Officer
Sold 15.1% of holdings ($7.1M position)31,667 shares left0.9x usual sizeFiling
- 2 Form 4 sale NVCRPlan not statedJan 5, 2023 +605 days
Sold 8,143 shares at $116.14 ($946k)
Weinberg Uri, Chief Science Officer
Sold 15.8% of holdings ($6M position)43,286 shares left1.4x usual sizeFiling
- 3 Form 144 notice NVCRNoticeFeb 28, 2025 +785 days
Filed to sell 4,637 shares ($87k)
Weinberg Uri, Officer
No 10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale NVCRNo planFeb 28, 2025 same day
Sold 4,637 shares at $18.75 ($87k)
Weinberg Uri, Chief Innovation Officer
No 10b5-1 planSold 2.7% of holdings ($3.2M position)166,511 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 144 notice NVCRNoticeMar 3, 2025 +3 days
Filed to sell 268 shares ($5k)
Weinberg Uri, Officer
No 10b5-1 planFiling
- 6 Form 4 sale NVCRNo planMar 3, 2025 same day
Sold 268 shares at $18.92 ($5k)
Weinberg Uri, Chief Innovation Officer
No 10b5-1 planSold 0.2% of holdings ($3.2M position)166,243 shares leftFollows a Form 144Filing
- 7 Form 4 sale NVCRNo planMar 2, 2026 +364 days
Sold 10,733 shares at $13.68 ($147k)
Weinberg Uri, Chf Medical and Innovation Ofr
No 10b5-1 planSold 4.6% of holdings ($3.2M position)223,477 shares leftFiling
- 8 Form 4 sale NVCRNo planMar 4, 2026 +2 days
Sold 6,412 shares at $13.31 ($85k)
Weinberg Uri, Chf Medical and Innovation Ofr
No 10b5-1 planSold 2.3% of holdings ($3.6M position)267,190 shares left1.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 5, 2026 | NVCR | Chf Medical and Innovation Ofr | Form 4 sale | 6,412 | $85k | 2.3% | No plan | SEC |
| Mar 2, 2026 | Mar 3, 2026 | NVCR | Chf Medical and Innovation Ofr | Form 4 sale | 10,733 | $147k | 4.6% | No plan | SEC |
| Mar 3, 2025 | Mar 4, 2025 | NVCR | Chief Innovation Officer | Form 4 sale | 268 | $5k | 0.2% | No plan | SEC |
| Mar 3, 2025 | Mar 3, 2025 | NVCR | Officer | Form 144 notice | 268 | $5k | Notice | SEC | |
| Feb 28, 2025 | Mar 3, 2025 | NVCR | Chief Innovation Officer | Form 4 sale | 4,637 | $87k | 2.7% | No plan | SEC |
| Feb 28, 2025 | Feb 28, 2025 | NVCR | Officer | Form 144 notice | 4,637 | $87k | Notice | SEC | |
| Jan 5, 2023 | Jan 9, 2023 | NVCR | Chief Science Officer | Form 4 sale | 8,143 | $946k | 15.8% | Plan not stated | SEC |
| May 10, 2021 | May 12, 2021 | NVCR | Chief Science Officer | Form 4 sale | 5,650 | $1.1M | 15.1% | Plan not stated | SEC |
| Mar 23, 2021 | Mar 25, 2021 | NVCR | Chief Science Officer | Form 4 sale | 3,892 | $545k | 9.7% | Plan not stated | SEC |
| Feb 22, 2021 | Feb 24, 2021 | NVCR | Chief Science Officer | Form 4 sale | 6,500 | $1.1M | 19.1% | Plan not stated | SEC |
| Sep 25, 2020 | Sep 28, 2020 | NVCR | Chief Science Officer | Form 4 sale | 15,250 | $1.6M | 35.6% | Unusual | SEC |